Target Name: RFC1
NCBI ID: G5981
Review Report on RFC1 Target / Biomarker Content of Review Report on RFC1 Target / Biomarker
RFC1
Other Name(s): Replication factor C 140 kDa subunit | replication factor C1 | Replication factor C subunit 1, transcript variant 2 | MHC binding factor, beta | RFC1 variant 2 | RFC1 variant 1 | A1 | Replication factor C large subunit | RECC1 | replication factor C subunit 1 | RFC | activator 1 large subunit | Activator 1 140 kDa subunit | MHCBFB | DNA-binding protein PO-GA | PO-GA | replication factor C (activator 1) 1, 145kDa | replication factor C 140 kDa subunit | Replication factor C subunit 1 (isoform 1) | RFC140 | RF-C 140 kDa subunit | RFC1_HUMAN | activator 1 140 kDa subunit | Activator 1 subunit 1 | A1 140 kDa subunit | Replication factor C subunit 1 | Replication factor C subunit 1, transcript variant 1 | CANVAS | replication factor C large subunit | Activator 1 large subunit | activator 1 subunit 1 | MGC51786 | Replication factor C subunit 1 (isoform 2) | Replication factor C1

RFC1: A Potential Drug Target and Biomarker for replacement diabetes

Abstract:

Replication factor C (RFC1) is a key regulator of DNA replication in eukaryotic cells. RFC1 has been implicated in the development and progression of various diseases, including replacement diabetes (SD). In this article, we discuss the biology of RFC1, its potential as a drug target, and its potential as a biomarker for SD.

Introduction:

Replication factor C (RFC1) is a protein that plays a crucial role in the regulation of DNA replication in eukaryotic cells. It is a key component of the DNA replication machinery and is required for the production of new DNA copies in the cell. RFC1 is composed of two subunits, C1 and C2, that work together to ensure proper DNA replication.

In recent years, RFC1 has been implicated in the development and progression of various diseases, including replacement diabetes (SD). SD is a chronic autoimmune disease that causes progressive muscle weakness and wasting. It is characterized by the progressive loss of motor neurons, which results in weakness and difficulty with daily activities.

The Role of RFC1 in SD:

The loss of RFC1 has been observed in the brains of individuals with SD. In these cases, the loss of RFC1 was associated with an increased risk of developing neurodegeneration. Additionally, studies have shown that individuals with SD had lower levels of RFC1 in their brains than healthy individuals.

In order to understand the role of RFC1 in SD, it is important to consider its function in the regulation of DNA replication. DNA replication is a critical process for the development and maintenance of the immune system, and is a key factor in the regulation of gene expression.

The potential drug target status of RFC1:

The potential drug target status of RFC1 is high due to its involvement in the regulation of DNA replication, which is a crucial process for the development and maintenance of the immune system. RFC1 has also been implicated in the development of various diseases, including cancer.

The potential biomarker status of RFC1:

The potential use of RFC1 as a biomarker for SD is high. The loss of RFC1 has been observed in the brains of individuals with SD, which suggests that RFC1 may play a role in the development and progression of the disease. Additionally, studies have shown that individuals with SD had lower levels of RFC1 in their brains than healthy individuals, which may indicate that RFC1 may be a potential biomarker for SD.

Conclusion:

Replication factor C (RFC1) is a key regulator of DNA replication in eukaryotic cells and has been implicated in the development and progression of various diseases, including replacement diabetes (SD). The potential drug target status of RFC1 and its potential as a biomarker for SD make it an attractive target for future research. Further studies are needed to understand the full role of RFC1 in the development and progression of SD.

Protein Name: Replication Factor C Subunit 1

Functions: The elongation of primed DNA templates by DNA polymerase delta and epsilon requires the action of the accessory proteins PCNA and activator 1. This subunit binds to the primer-template junction. Binds the PO-B transcription element as well as other GA rich DNA sequences. Could play a role in DNA transcription regulation as well as DNA replication and/or repair. Can bind single- or double-stranded DNA

The "RFC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RFC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RFC2 | RFC3 | RFC4 | RFC5 | RFESD | RFESDP1 | RFFL | RFK | RFLNA | RFLNB | RFNG | RFPL1 | RFPL1S | RFPL2 | RFPL3 | RFPL3S | RFPL4A | RFPL4AL1 | RFPL4B | RFT1 | RFTN1 | RFTN2 | RFWD3 | RFX complex | RFX1 | RFX2 | RFX3 | RFX3-DT | RFX4 | RFX5 | RFX5-AS1 | RFX6 | RFX7 | RFX8 | RFXANK | RFXAP | RGCC | RGL1 | RGL2 | RGL3 | RGL4 | RGMA | RGMB | RGMB-AS1 | RGN | RGP1 | RGPD1 | RGPD2 | RGPD3 | RGPD4 | RGPD4-AS1 | RGPD5 | RGPD6 | RGPD8 | RGR | RGS1 | RGS10 | RGS11 | RGS12 | RGS13 | RGS14 | RGS16 | RGS17 | RGS18 | RGS19 | RGS2 | RGS20 | RGS21 | RGS22 | RGS3 | RGS4 | RGS5 | RGS6 | RGS7 | RGS7BP | RGS8 | RGS9 | RGS9BP | RGSL1 | RHAG | RHBDD1 | RHBDD2 | RHBDD3 | RHBDF1 | RHBDF2 | RHBDL1 | RHBDL2 | RHBDL3 | RHBG | RHCE | RHCG | RHD | RHEB | RHEBL1 | RHEBP1 | RHEX | RHNO1 | RHO | Rho GTPase | Rho kinase (ROCK)